PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development of drug candidates in the clinical-testing phase. Puma Biotechnology specializes in the treatment of various forms of cancer. The company is headquartered in Los Angeles, California.
Country/Area ：Germany
Company Email ：support@pumabiotechnology.com
Industry ：BiotechnologyHealthcarePharmaceuticals
Company website ：*****
Company phone ：(424) 248-6500
Established ：2010
Company Revenue ：$230,120,000
Number of employees ：192
SIC Code ：28283
NAICS Code ：54541
Main Products ：Legal Notice |Annual Report ArchivesData Rights Request |
Company News
Read This Before Judging Puma Biotechnology, Inc.'s (NASDAQ:PBYI) ROE
Nov 18, 2023
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Nov 18, 2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Nov 6, 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 1, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 15,000 shares of Puma common stock to one new non-executive employee. The award was granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awar
Nov 6, 2023Puma Biotechnology Reports Third Quarter 2023 Financial ResultsNov 2, 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology issued its Q3-2023 earnings release on Nov. 2, 2023, and hosted a conference call to discuss the results of the quarter.
Nov 2, 2023Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial ResultsOct 19, 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, Nov. 2, 2023, following the release of its 3Q-2023 results.
Oct 19, 2023Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics MeetingOct 14, 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported findings from a Phase I/II study of Alisertib and pembrolizumab for Rb-Deficient HNSCC at the 2023 AACR-NCI-EORTC meeting
Oct 14, 2023Web Summary
Q1: What is the address of PUMA BIOTECHNOLOGY, INC.?
A1: The address of PUMA BIOTECHNOLOGY, INC. is Los Angeles, California.
Q2: What type of products does PUMA BIOTECHNOLOGY, INC. develop and commercialize?
A2: PUMA BIOTECHNOLOGY, INC. develops and commercializes novel therapeutics for the treatment of cancer.
Q3: In which industry is PUMA BIOTECHNOLOGY, INC. primarily involved?
A3: PUMA BIOTECHNOLOGY, INC. is primarily involved in the biopharmaceutical industry.
Q4: What services does PUMA BIOTECHNOLOGY, INC. offer?
A4: The provided text does not explicitly mention the services offered by PUMA BIOTECHNOLOGY, INC., but it can be inferred that they provide clinical trials, product pipeline management, and investor relations services as part of their business operations.
Q5: What is the contact information for PUMA BIOTECHNOLOGY, INC.'s investor relations department?
A5: The contact information for PUMA BIOTECHNOLOGY, INC.'s investor relations department is ir@pumabiotechnology.com.
Q6: How can investors get in touch with PUMA BIOTECHNOLOGY, INC. to inquire about inducement awards under Nasdaq Listing Rule 5635(c)(4)?
A6: Investors can contact PUMA BIOTECHNOLOGY, INC.'s investor relations department at ir@pumabiotechnology.com or through the company's website.
Q7: What is the phone number for PUMA BIOTECHNOLOGY, INC.'s main medical information line?
A7: The phone number for PUMA BIOTECHNOLOGY, INC.'s main medical information line is 1-844-MED-PUMA (1-844-633-7862).
Q8: What is the date of incorporation for PUMA BIOTECHNOLOGY, INC.?
A8: The provided text does not mention the exact date of incorporation for PUMA BIOTECHNOLOGY, INC., but it mentions that the company was founded in 2000 and incorporated in California.
A1: The address of PUMA BIOTECHNOLOGY, INC. is Los Angeles, California.
Q2: What type of products does PUMA BIOTECHNOLOGY, INC. develop and commercialize?
A2: PUMA BIOTECHNOLOGY, INC. develops and commercializes novel therapeutics for the treatment of cancer.
Q3: In which industry is PUMA BIOTECHNOLOGY, INC. primarily involved?
A3: PUMA BIOTECHNOLOGY, INC. is primarily involved in the biopharmaceutical industry.
Q4: What services does PUMA BIOTECHNOLOGY, INC. offer?
A4: The provided text does not explicitly mention the services offered by PUMA BIOTECHNOLOGY, INC., but it can be inferred that they provide clinical trials, product pipeline management, and investor relations services as part of their business operations.
Q5: What is the contact information for PUMA BIOTECHNOLOGY, INC.'s investor relations department?
A5: The contact information for PUMA BIOTECHNOLOGY, INC.'s investor relations department is ir@pumabiotechnology.com.
Q6: How can investors get in touch with PUMA BIOTECHNOLOGY, INC. to inquire about inducement awards under Nasdaq Listing Rule 5635(c)(4)?
A6: Investors can contact PUMA BIOTECHNOLOGY, INC.'s investor relations department at ir@pumabiotechnology.com or through the company's website.
Q7: What is the phone number for PUMA BIOTECHNOLOGY, INC.'s main medical information line?
A7: The phone number for PUMA BIOTECHNOLOGY, INC.'s main medical information line is 1-844-MED-PUMA (1-844-633-7862).
Q8: What is the date of incorporation for PUMA BIOTECHNOLOGY, INC.?
A8: The provided text does not mention the exact date of incorporation for PUMA BIOTECHNOLOGY, INC., but it mentions that the company was founded in 2000 and incorporated in California.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
